Step Into the Spotlight at the Innovation Exchange
Having launched at Advanced Therapies Europe 2025, the Innovation Exchange debuted as a high-impact pitching competition connecting pre-Series B biotech innovators with the industry’s leading investors, VCs, and strategic partners. A platform to get noticed, get feedback, and get connected. If you're building the future of cell and gene therapy in 2026, this is the moment to stand out.
Thank you to our 2025 finalists...
Developing a novel gene therapy technology that cuts complexity and cost and makes AAV manufacturing viable at scale - to reach more patients, more quickly, and in more disease areas.
What Is the Innovation Exchange?
The Innovation Exchange is a curated live pitching session taking place in September part of the main agenda at Advanced Therapies Europe. Attending startups will pitch in front of the entire conference audience and a selection panel made up of top-tier investors and pharma deal-makers.
Finalists will receive real-time feedback and the opportunity to gain funding, partnerships, and visibility across the global advanced therapies community.
The Innovation Exchange is open to pre-Series B startups across the cell and gene therapy ecosystem, including:
Want a preview of the ATE community?
See who was in the room this year and the organisations leading the way in advanced therapies.
Download the 2025 Attendee List
)
)
)
)
)
)
)
)
)
)
